Recent Articles from Business Wire

Global IT firm FPT announced its inclusion in Forrester’s The Digital Transformation Services Landscape, Q2 2025. The report provides an overview of 35 digital transformation service providers and offers valuable insights into the current market dynamics.

Walker & Dunlop, Inc. announced today that it has expanded its presence in Texas with a regional CBRE veteran, Mike Bryant. As senior managing director, based in and native to Dallas, Bryant will be responsible for new loan originations, with a focus on multifamily lending through government-sponsored enterprises (GSEs) such as Fannie Mae and Freddie Mac.

Advanced Energy Industries, Inc. (NASDAQ: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, today announced that its board of directors has authorized a quarterly cash dividend of $0.10 per share, payable on June 6, 2025 to shareholders of record as of May 24, 2025.

Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its Board of Directors has appointed Ashley McEvoy President and Chief Executive Officer and a member of the Board of Directors, effective immediately.

Peridio, the platform for building and maintaining advanced embedded products, today announced Avocado OS, its groundbreaking open-source Embedded Linux distribution designed to reshape the embedded product development lifecycle. Avocado OS delivers a seamless developer while providing robust security, reliability, and deterministic performance essential for complex embedded products.

Abnormal AI, the leader in AI-native human behavior security, today unveiled its most ambitious product release to date—introducing autonomous AI agents that revolutionize how organizations train employees and report on risk, while also evolving its email security capabilities to continue to stop the world’s most advanced email attacks. In a year defined by the explosive use of malicious AI for cybercrime, Abnormal is doubling down on its mission to protect people. With its AI-native platform, Abnormal’s newest innovations bring intelligent automation to security awareness training, executive reporting, and advanced email threat detection.

Cyware, the leader in AI-powered threat intelligence management, intelligence sharing and collaboration, as well as hyper-orchestration and response, has been named the 2025 winner of Security Today’s prestigious GOVIES Award for innovation in AI-driven Cyber Threat Management.

Revvity, Inc. (NYSE: RVTY), today reported financial results for the first quarter ended March 30, 2025.

Konovo, a technology-first healthcare intelligence company, formally launched today with a new mission to simplify and enable research across the insights ecosystem of researchers, vendors and data sources. Building on a long history of success in research under three separate brands, Konovo applies technology to address the industry’s longstanding challenges: fragmentation, isolated learnings, and disengaged responders, all of which cause delays, reduce efficiencies, and affect quality. Fueled by new leadership, vision, and technology investment, Konovo is expanding the industry’s first AI-native, intelligent platform to streamline and accelerate deeper insights – rooted in its track record of award-winning AI innovations pioneered by InCrowd, SHG and GlocalMind.

Experian Health today released its annual 2025 State of Patient Access Survey, which reveals some alignment between patients and providers but also a few areas of polarization. Patient and provider respondents said access “was about the same” at the highest levels since 2022 (68% and 43%, respectively) and fewer patients are saying that access is worse compared to previous years, which may reflect an overall better experience. Among those that say access is better (16%), the top reason is they can see a practitioner quickly. However, the top challenge for patients that say access is worse (15%) remains being able to see a provider quickly while, ironically, the biggest challenge for providers is getting patients to use the digital access services designed to help remedy this issue.

Seasons Federal Credit Union is embracing a bold new chapter, rebranding as Ellafi Federal Credit Union on April 28, 2025. As it celebrates 90 years of service and 20 years as Seasons, the credit union is evolving to better serve its members and community, with a mission centered on financial independence and economic resilience for women and their allies, collectively referred to as women+.

Underoutfit, a fast-growing brand in women’s intimates, is launching its first national linear television campaign this week in partnership with All-Inclusive TV agency Marketing Architects.

Acuity Knowledge Partners (Acuity), a leading provider of bespoke technology, analytics, and research to the financial services sector, is excited to announce the launch of a market leading, deep domain specific Agentic AI platform - Agent Fleet for Banks, Asset Managers, and Private Equity houses.

Continuing an over two decade-long tradition of bringing together employees to volunteer in their local communities, Charles Schwab will again host Schwab Volunteer Week across the country. Taking place April 28-May 9, this year’s event will focus on serving nearly 350 nonprofits across the U.S. through more than 10,000 volunteer opportunities.

Astoriom, a global leader in the R&D sample stability and biorepository storage industry, today announced the appointment of Ryan Smith as Global Head of Sales. He will build on the strong foundation already in place to further scale Astoriom’s portfolio of sample stability storage, biorepository storage, disaster protection and recovery, as well as sample storage equipment and validation services. Ryan’s appointment demonstrates the company’s commitment to its evolving commercial strategy and continued expansion in key markets worldwide, enabling scientists to safeguard the integrity and viability of their valuable sample assets to advance their research.

Metrion Biosciences (“Metrion”), the specialist preclinical contract research organisation (CRO) and a global leader in ion channel services, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Leveraging over a decade of electrophysiology expertise, the NaV1.9 assay, alongside Metrion’s unique combination of ion channel expertise, bespoke assays and pain research services, enables researchers to overcome traditional limitations of NaV1.9 screening and generate reproducible and decision-ready data.

The "Post Event Analysis - Australian Open 2025" report has been added to ResearchAndMarkets.com's offering.

RSA 2025 - CrowdStrike (NASDAQ: CRWD) today unveiled Charlotte AI Agentic Response and Charlotte AI Agentic Workflows, marking a leap forward in modern SOC operations. Combined with the previously announced Charlotte AI Agentic Detection Triage, Charlotte AI transcends “ask-and-respond” copilots, delivering autonomous reasoning and action on first- and third-party data. The AI-native CrowdStrike Falcon® platform is now cybersecurity’s intelligent reasoning AI platform, drawing conclusions without human prompts and taking action with bounded autonomy.

Mitsubishi Electric Corporation (TOKYO: 6503) announced today that the company’s Board of Directors resolved on April 28, 2025 to repurchase shares of the company’s stock, as shown below, pursuant to the provisions of Article 459, paragraph 1 of the Companies Act, as well as Article 31 of the company’s articles of incorporations.

Mitsubishi Electric Corporation (TOKYO: 6503) announced today its consolidated financial results for fiscal 2025 (April 1, 2024 - March 31, 2025).

Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a Stamford, Connecticut-based commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced the companies have entered into a definitive agreement for Merck KGaA, Darmstadt, Germany, to acquire SpringWorks. The purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3.4 billion (€3.0 billion) based on SpringWorks’ cash balance as of December 31, 2024, and a premium of 26% to SpringWorks’ unaffected 20-day volume-weighted average price of $37.38 on February 7, 2025, the day prior to the first market speculation of a potential transaction between Merck KGaA, Darmstadt, Germany, and SpringWorks.

Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS.

Regulatory News:

Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V., a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth of Independent States Region.

An innovative bin monitoring system that enables feed mill operators to access real-time bin levels, 24/7, eliminating the need for the hazardous practice of manual bin dropping is launching in the United States.

Swissport International, a leading provider of ground services and cargo handling for the aviation sector, has announced a strategic partnership with global safety and quality software company Ideagen to accelerate their 2030 Vision of Zero Harm. This collaboration will enable Swissport to share information with governing bodies more easily to drive safety compliance.

Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, recently received congratulatory messages and unwavering outpouring of support from California political leaders on the Company’s Bridge Strategy, it’s FX brand and the recent appointment of YT Jia to the position of Co-CEO of the Company. The remarks were made at the Company’s recent ‘FF Stockholder Community and FX Co-Creation Day’ event held at FF’s headquarters in Los Angeles. During the meeting, both government as well as Company leaders gave pertinent updates on FF, the FX brand as well as congratulatory messages on YT’s appointment as Co-CEO. YT also gave a number of new business updates and key transformational aspirations for the Company moving forward.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Skyworks Solutions, Inc. (NASDAQ: SWKS) between July 30, 2024 and February 5, 2025. Skyworks describes itself as a “developer, manufacturer, and provider of analog and mixed-signal semiconductor products and solutions for numerous applications, including aerospace, automotive, broadband, cellular infrastructure, connected home, defense, entertainment and gaming, industrial, medical, smartphone, tablet, and wearables.”

Valnet Inc. (“Valnet”) and its Co-Founder and CEO, Hassan Youssef, have filed a lawsuit in the United States District Court for the District of Delaware against The Wrap News Inc. (“The Wrap”) for defamation, unfair competition and other illegal actions taken by The Wrap in connection with an article published by The Wrap on March 20, 2025 smearing Valnet and Mr. Youssef.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights a duration of response of nearly four years from a long-term follow-up study with JELMYTO® (mitomycin) for pyelocalyceal solution, which is FDA-approved for the treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients.

Phixius by Nacha—a secure, peer-to-peer payment information network—announced today that ValidiFI is live on the Phixius network as an additional provider of bank account validation. Phixius now offers multiple providers of account validation, expanding the coverage of account validation data for Phixius users.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced patient-reported outcomes following treatment of patients with low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) that showed investigational drug UGN-102 (mitomycin) for intravesical solution achieved robust and durable complete response (CR) rates without negatively impacting quality of life. The data (Moderated Poster - MP15) were presented at the AUA 2025 Annual Meeting in Las Vegas, Nevada.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced new data from the OPTIMA II Phase 2b study of UGN‑102 (mitomycin) for intravesical solution demonstrate clinically meaningful two-year duration of response (24.2 months) by Kaplan-Meier analysis. UGN-102 is UroGen’s sustained-release formulation of mitomycin being developed for the treatment of recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers and acquirers of Geron Corporation (NASDAQ: GERN) securities between February 28, 2024 and February 25, 2025. Geron is a commercial-stage biopharmaceutical company.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the Phase 3 KEYNOTE-689 trial evaluating KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, as a perioperative treatment regimen for patients with stage III or IVA, resected, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Results at the first interim analysis of the trial showed KEYTRUDA significantly improved event-free survival (EFS) as part of a perioperative treatment regimen with adjuvant standard of care (SOC) radiotherapy with or without cisplatin compared to adjuvant standard of care (SOC) radiotherapy with or without cisplatin alone in patients with resectable LA-HNSCC. These data are being presented for the first time today during a Plenary Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 (Abstract #CT001) and were selected for the AACR press program.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Fluence Energy, Inc. (NASDAQ: FLNC) between November 29, 2023 and February 10, 2025. Fluence describes itself as a company that “offers energy storage products and solutions, delivery services, recurring operational and maintenance services, and digital applications and solutions for energy storage and other power assets.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Ready Capital Corporation (NYSE: RC) between November 7, 2024 and March 2, 2025. Ready Capital describes itself as a real estate finance company.

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against Geron Corporation (“Geron”) (NASDAQ: GERN) on behalf of those who purchased or otherwise acquired Geron securities between February 28, 2024, and February 25, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 12, 2025.

Swimlane, AI hyperautomation for the entire security organization, today announced it has been named the “Most Valuable Pioneer” in AI maturity by QKS Group. In the 2025 QKS AI Maturity Matrix™, Swimlane ranks ahead of seven other vendors for its AI-first productization, advanced vision and agentic AI roadmap. Swimlane is ranked ahead of Palo Alto Networks, Cisco, D3, Tines, Fortinet, Torq and Anomali.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025. Maravai is a life sciences company which provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of TFI International Inc. (NYSE: TFII) between April 26, 2024 and February 19, 2025. TFI International is a transportation and logistics company.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Rocket Lab USA, Inc. (NASDAQ: RKLB) between November 12, 2024 and February 25, 2025. Rocket Lab describes itself as a “space company which provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing and other spacecraft and on-orbit management solutions.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024. Elf describes itself as a company that “provides cosmetic and skin care products.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of Quantum Computing Inc. (NASDAQ: QUBT) between March 30, 2020 and January 15, 2025. Quantum Computing describes itself as an “American company that purportedly utilizes non-linear quantum optics to deliver quantum products for high-performance computing applications.”

Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients.

EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on partnering with and scaling software and technology-enabled businesses.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced an updated 18-month DOR of 80.6% (95% CI: 74.0, 85.7), by Kaplan-Meier estimate, from the Phase 3 ENVISION trial of UGN-102 (mitomycin) for intravesical solution, an investigational treatment for recurrent LG-IR-NMIBC. These data were featured today in an Oral Presentation Session (Abstract ID: PD12) at the AUA 2025 Annual Meeting in Las Vegas, Nevada.

Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus Calmette-Guérin (BCG) as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically significant improvement with sasanlimab in combination with BCG (induction and maintenance) as compared to BCG alone (induction and maintenance): Hazard Ratio (HR) of 0.68; 95% Confidence Interval (CI), 0.49-0.94; 2-sided p=0.019; median EFS not yet reached. These findings show a 32% reduction in risk of disease-related events, including high-grade disease recurrence or progression, with the sasanlimab combination regimen as compared with SOC treatment alone. Pre-specified subgroup analyses for patients harboring higher risk disease showed consistent benefit with EFS HR of 0.63 (0.41, 0.96) for T1 disease, and EFS HR 0.53 (0.29, 0.98) for those with CIS disease.

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Napco Security Technologies, Inc. (“Napco” or “the Company”) (NASDAQ: NSSC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced encouraging safety data from the Phase 1 dose-escalation study for UGN-301 (zalifrelimab) intravesical solution, an investigational drug in development for the treatment of recurrent non-muscle invasive bladder cancer (NMIBC).

Diamond Comic Distributors (“Diamond” or “the Company”), today announced that it will no longer be moving forward in the transaction process with Alliance Entertainment.

Please replace the release dated April 23, 2025, with the following corrected version due to multiple revisions.

US Metro Bancorp (OTCQX: USMT): US Metro Bancorp (“Bancorp”) is a bank holding company, with a single subsidiary, US Metro Bank (“Bank”). On a consolidated basis, Bancorp earned $2.6 million in the first quarter of 2025, compared to $1.7 million in the fourth quarter of 2024. For the three months ending March 31, 2025, the consolidated Bancorp earned $2.6 million compared to $1.5 million for the three months ending March 31, 2024. On a year-to-date basis, Bancorp recorded an annualized return on average assets (“ROAA”) of 0.73% and an annualized return on average equity (“ROAE”) of 10.10%. With 16,520,000 shares outstanding, earnings per share (“EPS”) for the first quarter of 2025 was $0.16 compared to $0.11 in the fourth quarter of 2024. For the three months ending March 31, 2025, EPS was $0.16 compared to $0.09 for the three months ending March 31, 2024. On March 31, 2025, Bancorp’s book value per share was $6.29 compared to $5.87 a year earlier.

Marti Technologies, Inc. (“Marti”) (NYSE American: MRT), Türkiye’s leading mobility super app, will announce its full year 2024 financial and operational results before the U.S. markets open on Tuesday, April 29, 2025.

Resecurity, a U.S.-based cybersecurity company specializing in threat intelligence and digital risk management, successfully exhibited at MILIPOL India 2025, held from April 23–25 at India International Convention and Expo Centre (IICC), Dwarka, New Delhi. The event served as a premier meeting point for global leaders in homeland security, defense technology, and public safety.

The Law Offices of Frank R. Cruz reminds investors of the upcoming April 28, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Quantum Computing Inc. ("Quantum Computing" or the Company") (NASDAQ: QUBT) securities between March 30, 2020 and January 15, 2025, inclusive (the “Class Period”).

Visual Matrix, a leading provider of advanced technology solutions for the hospitality industry, announced a new partnership with Dubai’s Best Western Premier M Four Hotel. The Best Western Premier will receive access to Visual Matrix’s cutting-edge Property Management System, supporting full mobile operations and promoting greater efficiency and profitability.

Orbia Advance Corporation, S.A.B. de C.V. (“Orbia”) (BMV: ORBIA*), announces that today, it launched an offer to purchase for cash (the “Tender Offer”) any and all of the outstanding 1.875% Senior Notes due 2026 issued by Orbia (the “Notes”).

KBRA assigns preliminary ratings to six classes of mortgage pass-through notes from GCAT 2025-NQM1 Trust, a $438.2 million non-prime RMBS transaction. The underlying collateral, comprising 764 residential mortgages, is characterized by a significant concentration of loans underwritten using alternative income documentation. Borrowers in the subject pool possess a non-zero WA original credit score of 756 and exhibit modest equity in each mortgaged property, with WA LTV and combined LTV (CLTV) ratios of 69.5% and 69.5%, respectively.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR) investors concerning the Company’s possible violations of the federal securities laws.

First paragraph, first sentence of release should read: University of Phoenix is pleased to announce the release of its new Admissions Guide as an extensive resource helping students and prospective students understand the admissions process including degree opportunities, programmatic accreditation, student support services, and ways to reduce education costs. (instead of: University of Phoenix is pleased to announce the release of its new as an extensive resource helping students and prospective students understand the admissions process including degree opportunities, programmatic accreditation, student support services, and ways to reduce education costs).

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) resulting from allegations that Aldeyra may have issued materially misleading business information to the investing public.

Law Offices of Howard G. Smith announces an investigation on behalf of Landstar System, Inc. (“Landstar” or the “Company”) (NASDAQ: LSTR) investors concerning the Company’s possible violations of federal securities laws.

As part of its Earth Week celebration, Fullerton College held a ribbon cutting ceremony to commemorate the completion of a new solar canopy system developed in partnership with ForeFront Power, a leading developer and asset manager of commercial and industrial-scale solar energy and storage projects. The 1 megawatt-DC (MW DC) solar parking canopy array, located in Student Parking Lot 5 adjacent to Sherbeck Field, is projected to save Fullerton College nearly $6 million in energy costs over the next 20 years.

Lubrizol requests that their press release NewsItemId: 20250425022439 “Lubrizol Enters Nutraceutical Ingredient Distribution Partnership with Palmer Holland Inc. to Expand U.S. Reach” be killed.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into NAPCO Security Technologies, Inc. (NasdaqGS: NSSC).

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Virtu Financial, Inc. (NasdaqGS: VIRT).

Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the election of Lynda Cloud to its Board of Directors, effective April 23, 2025. This appointment reflects Herbalife’s continued commitment to innovation, digital transformation, and personalized wellness.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Extreme Networks, Inc. (NasdaqGS: EXTR).

Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, will release its second-quarter fiscal 2025 results Wednesday, May 7, 2025, after the markets close. The company’s president and CEO, Edward C. Dowling Jr., and CFO, Peter Fjellman, will discuss these results on a conference call on Thursday, May 8, 2025, at 9:30 a.m. ET.

Energy Vault Holdings, Inc. (“Energy Vault”) (NYSE: NRGV), a global energy storage company today announced that, effective on March 5, 2025, the Compensation Committee of Energy Vault’s Board of Directors granted to 12 new, non-executive employees, restricted stock unit awards covering 637,600 shares of its common stock under the Energy Vault Holdings, Inc. 2022 Employment Inducement Award Plan (as amended and/or restated, the “Inducement Award Plan”). The restricted stock units were granted as inducements material to the employees entering into employment with Energy Vault in accordance with New York Stock Exchange Listing Rule 303A.08.

Sunny Day, the beautiful new song and video from Antigua’s Reggae Ambassador, Causion, has officially launched on all major streaming platforms.

Today, consumer-rights law firm FeganScott announced that it has launched an investigation into Blue Shield of California, one of the largest healthcare insurance providers in the country, following confirmation from the company and the United States Department of Health and Human Services that the company had shared private health information and site user data with Google’s advertising products, Google Ads and Google Analytics.

Researchers with City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, will present more than 74 chaired, plenary, educational, minisymposium, poster and other sessions on innovative clinical trial results, breakthrough diagnostic techniques and advances in treatment options at the AACR Annual Meeting, which started April 25 and ends April 30 in Chicago.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Pacific Premier Bancorp, Inc. (NasdaqGS: PPBI) to Columbia Banking System, Inc. (NasdaqGS: COLB). Under the terms of the proposed transaction, shareholders of Pacific will receive 0.9150 of a share of Columbia for each share of Pacific that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.